Back to search
FDAFDA · Food and drugs·Recall number Z-2169-2026

QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp.

Published May 20, 2026 · Recall initiated: April 6, 2026

Summary

FDA records medical device Class II recall Z-2169-2026, published May 20, 2026 and initiated April 6, 2026. Recalling firm: Quidel Corporation; Status: Ongoing; Reported quantity: 12279 units; Lot: UDI/DI 30014613201083, Lot Numbers: 225788, 228322, 233274. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product has the potential for false positive results

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Quidel Corporation
Distributor
US Nationwide distribution in the states of AL, CA, FL, ID, IL, LA, MA, MD, MN, MO, NY, PA, SC, TN, TX, VA.
Lot
UDI/DI 30014613201083, Lot Numbers: 225788, 228322, 233274.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp. recalled?

Yes. FDA published recall Z-2169-2026 on May 20, 2026. Reported hazard: Product has the potential for false positive results

What should I do if I have this product?

Voluntary: Firm initiated · Letter